Related Experiment Video
Updated: May 13, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Longitudinal changes in serum protein levels are associated with disability progression in multiple sclerosis
Luis Sanz Andreu1, José Carlos Villoria Martín1, Alejandro Hernández Muñoz2
1Departamento de Bioquímica y Biología Molecular. Universidad de Salamanca. Salamanca. Spain.
Multiple Sclerosis and Related Disorders
|May 12, 2026
Summary
Lower serum protein levels may indicate an increased risk of multiple sclerosis (MS) progression to secondary progressive MS (SPMS). These accessible biomarkers could aid in long-term patient monitoring.
Area of Science:
- Neurology
- Biochemistry
- Medical Diagnostics
Background:
- Identifying patients with multiple sclerosis (MS) at risk of transitioning from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) is a clinical challenge.
- Current magnetic resonance imaging (MRI) markers may not fully predict disease progression.
- Accessible biochemical markers are needed for improved long-term monitoring of disability progression in MS.
Purpose of the Study:
- To investigate the association between serum and cerebrospinal fluid (CSF) biomarkers and the clinical transition from RRMS to SPMS.
- To explore the potential of accessible biochemical markers for predicting disability progression in MS patients.
Main Methods:
- Retrospective observational study of 45 MS patients.
- Analysis of clinical, radiological, and biochemical parameters, including CSF and serum biomarkers.
- Comparison of biomarkers between patients who remained RRMS and those who progressed to SPMS, using non-parametric tests and Spearman correlation.
Main Results:
- Lower serum albumin and total protein levels were observed in patients who later developed SPMS compared to those who remained RRMS.
- Serum ferritin levels decreased over time in RRMS patients, while albumin and total protein remained stable.
- No significant association was found between MRI activity and disease progression; total serum protein levels inversely correlated with EDSS scores.
Conclusions:
- Reduced serum protein levels may precede the clinical transition to SPMS and are linked to disability progression.
- Despite not being independent predictors, serum proteins are accessible and may support longitudinal monitoring strategies for MS.
- Further research into biochemical markers can enhance the management of MS progression.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...